Skip to content

LONA LONA Other income, net (Note 6)

Other income, net (Note 6) at other companies

Arvinas logo
ArvinasARVN
-$100K
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
$121K+403%
Aura Biosciences, Inc. logo
Aura Biosciences, Inc.AURA
$2K+108%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
-$12K+76.0%
Erasca, Inc. logo
Erasca, Inc.ERAS
$22K+129%
Dogwood Therapeutics logo
Dogwood TherapeuticsDWTX
$90.95K+101%

Other financials

Income statement

See full
Operating income-$17.2M-80.5%
Net income-$32.9M-260%
EPS (diluted)-$1.73+26.1%

Balance sheet

See full
Cash & equivalents$32.8M+24.3%
Total debt$691.0K-38.2%
Total equity$49.3M+32.1%
Total assets$71.6M+64.5%

Cash flow

See full
Operating cash flow-$20.9M-42.5%
CapEx$28.0K-15.2%
Free cash flow-$26.0M+1.1%

Valuation

See full
Market cap$86.33M+223%
Enterprise value$54.18M

Returns & leverage

See full
Return on equity-298.8%-726pp
Debt / equity0.0×
Current ratio10.4×+3.1×

Where this comes from

Reported directly by LONA in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: LONA’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about LONA's other income, net (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LONA's other income, net (note 6)?
LONA (LONA) reported other income, net (note 6) of $586K in Q1 2026.
How has LONA's other income, net (note 6) changed year-over-year?
LONA's other income, net (note 6) increased by 49.1% year-over-year, from $393K to $586K.
What is the long-term trend for LONA's other income, net (note 6)?
Over 4 years (2021 to 2025), LONA's other income, net (note 6) has grown at a 38.7% compound annual growth rate (CAGR), from $334K to $1.24M.
What does other income, net (note 6) mean?
This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.